9月3日，和铂医药-B盘初涨超8%，GIC斥资超5亿港元增持公司股份，持股比例突破6%。
消息面上，根据香港联交所披露文件，8月29日，新加坡政府投资公司(GIC)增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,397.7万股股份，好仓比例由1.62%升至6.37%。
值得注意的是，和铂医药近日公布中期业绩，收入约1.01亿美元，同比增长约3.27倍；期内溢利7299.9万美元，同比增长51.25倍。公司近期公布，拟配售合共4502.2万股新股份，占扩大后股本5.17%，每股配售价11.5港元，预计配售事项所得款项净额5.12亿港元，约50%将用于开拓创新药物资产的研发；约40%将用于推进现有管线药物资产的临床试验；及约10%将用于营运资金及其他一般企业用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
